| European Case Law Identifier: | ECLI:EP:BA:2012:R000312.20120829 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 29 August 2012 | ||||||||
| Case number: | R 0003/12 | ||||||||
| Petition for review of: | T 0626/08 | ||||||||
| Application number: | 01952097.2 | ||||||||
| IPC class: | A61K 31/4355 A61P 35/00 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | B | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Use of cyclopamine in the treatment of basal cell carcinoma and other tumors | ||||||||
| Applicant name: | Tas, Sinan | ||||||||
| Opponent name: | Curis, Inc. | ||||||||
| Board: | EBA | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: | |||||||||
| Keywords: | Submissions with respect to Art. 113 EPC not substantiated Petition for review clearly inadmissible |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/r120003eu1.html
Date retrieved: 17 May 2021
